GlycoMimetics Inc (GLYC)
0.387
-0.02
(-5.61%)
USD |
NASDAQ |
Nov 05, 14:29
GlycoMimetics Market Cap: 24.96M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 26.44M |
| November 01, 2024 | 24.67M |
| October 31, 2024 | 26.24M |
| October 30, 2024 | 29.44M |
| October 29, 2024 | 31.60M |
| October 28, 2024 | 10.85M |
| October 25, 2024 | 11.16M |
| October 24, 2024 | 11.21M |
| October 23, 2024 | 11.45M |
| October 22, 2024 | 10.64M |
| October 21, 2024 | 10.32M |
| October 18, 2024 | 10.21M |
| October 17, 2024 | 10.22M |
| October 16, 2024 | 10.12M |
| October 15, 2024 | 9.827M |
| October 14, 2024 | 9.582M |
| October 11, 2024 | 9.679M |
| October 10, 2024 | 9.305M |
| October 09, 2024 | 9.254M |
| October 08, 2024 | 9.853M |
| October 07, 2024 | 10.06M |
| October 04, 2024 | 10.30M |
| October 03, 2024 | 10.33M |
| October 02, 2024 | 9.930M |
| October 01, 2024 | 10.69M |
| Date | Value |
|---|---|
| September 30, 2024 | 10.90M |
| September 27, 2024 | 10.77M |
| September 26, 2024 | 10.99M |
| September 25, 2024 | 10.29M |
| September 24, 2024 | 10.61M |
| September 23, 2024 | 10.61M |
| September 20, 2024 | 10.63M |
| September 19, 2024 | 10.96M |
| September 18, 2024 | 10.58M |
| September 17, 2024 | 10.64M |
| September 16, 2024 | 10.46M |
| September 13, 2024 | 10.96M |
| September 12, 2024 | 10.58M |
| September 11, 2024 | 10.47M |
| September 10, 2024 | 10.23M |
| September 09, 2024 | 10.53M |
| September 06, 2024 | 10.13M |
| September 05, 2024 | 10.61M |
| September 04, 2024 | 10.37M |
| September 03, 2024 | 10.97M |
| August 30, 2024 | 11.37M |
| August 29, 2024 | 11.17M |
| August 28, 2024 | 10.96M |
| August 27, 2024 | 11.61M |
| August 26, 2024 | 12.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.254M
Minimum
Oct 09 2024
281.84M
Maximum
Nov 14 2019
111.30M
Average
107.72M
Median
Sep 16 2021
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.53B |
| Arbutus Biopharma Corp | 739.08M |
| FibroGen Inc | 31.33M |
| Cidara Therapeutics Inc | 93.96M |
| Cue Biopharma Inc | 100.55M |
Market Cap Related Metrics
| Price to Book Value | 1.244 |
| Price | 0.387 |
| Earnings Yield | -157.6% |